SANGUINE
Live / Registered — Registered (as of 24 Dec 2024)
What this means for you
Registered since 24 Dec 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98097064
- Registration number
- 7618441
- Mark type
- Design + words
- Filed
- 21 Jul 2023
- Published for opposition
- 05 Nov 2024
- Registered
- 24 Dec 2024
- Attorney of record
- Elizabeth Oliner
Goods and services
- Class 042 — Scientific and technological services: Research laboratory analysis of biospecimens for cell analysis assays, cell count, immunophenotyping, and HLA typing for use in infectious disease research; Research laboratory services providing biospecimen analysis, cell analysis assays, cell count, immunophenotyping, and HLA typing for use in infectious disease research; Compiling data for research purposes in the field of medical science and medical consultancy; Medical and scientific research in the fields of autoimmune diseases, genetic disorders, neurological disorders, oncology, infectious diseases, and immunology related to biomarker discovery and validation, drug discovery and development, diagnostics development, and translational applications; Providing an online searchable database in the field of autoimmune diseases, genetic disorders, neurological disorders, oncology, infectious diseases, immunology and health for scientific research purposes; Providing an online searchable database in the field of biospecimen and data collection for scientific research purposes; Providing information about medical research in the field of autoimmune diseases, genetic disorders, neurological disorders, oncology, infectious diseases, and immunology for purposes including biomarker discovery and validation, drug discovery and development, diagnostics development, and other translational applications; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Scientific laboratory services; Scientific research for medical purposes in the field of autoimmune diseases, genetic disorders, neurological disorders, oncology, infectious diseases, immunology, biomarker discovery and validation, drug discovery and development, diagnostics development, and translational applications; Scientific research in the field of autoimmune diseases, genetic disorders, neurological disorders, oncology, infectious diseases, oncology and health research; Providing biospecimen collection and data collection for scientific research purposes in the field of autoimmune diseases, genetic disorders, neurological disorders, oncology, infectious diseases, immunology, biomarker discovery and validation, drug discovery and development, diagnostics development, and translational applications
Owner
- Sanguine Biosciences, Inc., Woburn, MA, US
- Sanguine Biosciences, Inc., Woburn, MA, US
- Sanguine Biosciences, Inc., Woburn, MA, US
Prosecution history
- 24 Dec 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 24 Dec 2024 — REGISTERED-PRINCIPAL REGISTER
- 05 Nov 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 05 Nov 2024 — PUBLISHED FOR OPPOSITION
- 16 Oct 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 26 Sept 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 03 Sept 2024 — EXAMINER'S AMENDMENT ENTERED
- 03 Sept 2024 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 03 Sept 2024 — EXAMINERS AMENDMENT E-MAILED
- 03 Sept 2024 — EXAMINERS AMENDMENT -WRITTEN
- 29 Aug 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 29 Aug 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 29 Aug 2024 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 02 Jul 2024 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 02 Jul 2024 — FINAL REFUSAL E-MAILED